Calliditas Therapeutics

Calliditas Therapeutics is a specialty pharmaceutical company that develops medicines in areas of unmet medical need. Its products include Nefecon (a drug for treating IgA nephropathy) and Busulipo (an alternative for bone marrow ablation prior to bone marrow transplantation). The company was founded in 1991 and is headquartered in Stockholm, Sweden.